New SSP issued for Combisal®125mcg/25mcg inhalers

In response to a significant ongoing supply disruption affecting Combisal® 125micrograms / 25micrograms inhaler, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective 22 July 2022, SSP034 authorised by the Secretary of State, has been developed by clinicians and provides pharmacists with procedures to follow in providing a suitable [...]

The post New SSP issued for Combisal®125mcg/25mcg inhalers appeared first on PSNC Website.